The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats

Archives Italiennes de Biologie

Volumn 149, Issue 2, 2011, Pages 205-213

  Tirasa, P ^a  

^a CNR   (Italy)

Author keywords

Eye drops; Neuronal precursors; Neurotrophins; p75NTR; Subventricular zone

Indexed keywords

KI 67 ANTIGEN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ADULT STEM CELL; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; HEMISPHERIC DOMINANCE; INTRAOCULAR DRUG ADMINISTRATION; LATERAL BRAIN VENTRICLE; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TIME;

ADMINISTRATION, OPHTHALMIC; ADULT STEM CELLS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CELL DIFFERENTIATION; CELL PROLIFERATION; FUNCTIONAL LATERALITY; KI-67 ANTIGEN; LATERAL VENTRICLES; MALE; NERVE GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 79958161603     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Aloe L., Tirassa P., Bracci-Laudiero L. Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Des., 7: 113-123, 2001.
2. Aloe L., Tirassa P., Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol. Res., 54: 253-258, 2008.
3. Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. J. Neurosci., 22: 629-634, 2002.
4. Apfel S.C., Schwartz S., Adornato B.T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J.C., Barbano R., Dyck P.J. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. JAMA, 284: 2215-2221, 2000.
5. Bath K.G. and Lee F.S. Neurotrophic factor control of adult SVZ neurogenesis. Dev. Neurobiol., 70: 339-349, 2010.
6. Benoit B.O., Savarese T., Joly M., Engstrom C.M., Pang L., Reilly J., Recht L.D., Ross A.H., Quesenberry P.J. Neurotrophin channeling of neural progenitor cell differentiation. J. Neurobiol., 46: 265-280, 2001.
7. Bocchini V. and Angeletti P.U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl. Acad. Sci. U.S.A., 64: 787-794, 1969.
8. Cameron H.A. and McKay R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Comp. Neurol., 435: 406-417, 2001.
9. Cattaneo E. and McKay R. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature, 347: 762-765, 1990.
10. Colafrancesco V., Parisi V., Sposato V., Rossi S., Russo M.A., Coassin M., Lambiase A., Aloe L. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma. J. Glaucoma, in press, 2010.
11. Connor B. and Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Brain Res. Rev., 27: 1-39, 1998.
12. Curtis M.A., Faull R.L., Eriksson P.S. The effect of neurodegenerative diseases on the subventricular zone. Nat. Rev. Neurosci., 8: 712-723, 2007.
13. De Rosa R., Garcia A.A., Braschi C., Capsoni S., Maffei L., Berardi N., Cattaneo A. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl. Acad. Sci. U.S.A., 102: 3811-3816, 2005.
14. Di Fausto V., Fiore M., Tirassa P., Lambiase A., Aloe L. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur. J. Neurosci., 26: 2473-2480, 2007.
15. Duman R.S. and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry, 59: 1116-1127, 2006.
16. Eriksdotter Jonhagen M., Nordberg A., Amberla K., Backman L., Ebendal T., Meyerson B., Olson L., Seiger Shigeta M., Theodorsson E., Viitanen M., Winblad B., Wahlund L.O. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 9: 246-257, 1998.
17. Fiore M., Triaca V., Amendola T., Tirassa P., Aloe L. Brain NGF and EGF administration improves passive avoidance response and stimulates brain precursor cells in aged male mice. Physiol. Behav., 77: 437-443, 2002.
18. Fiore M., Amendola T., Triaca V., Tirassa P., Alleva E., Aloe L. Agonistic encounters in aged male mouse potentiate the expression of endogenous brain NGF and BDNF: possible implication for brain progenitor cells' activation. Eur. J. Neurosci., 17: 1455-1464, 2003.
19. Gascon E., Vutskits L., Zhang H., Barral-Moran M.J., Kiss P.J., Mas C., Kiss J.Z. Sequential activation of p75 and TrkB is involved in dendritic development of subventricular zone-derived neuronal progenitors in vitro. Eur. J. Neurosci., 21: 69-80, 2005.
20. Giuliani A., D'Intino G., Paradisi M., Giardino L., Calzà L. p75(NTR)-immunoreactivity in the subventricular zone of adult male rats: expression by cycling cells. J. Mol. Histol., 35: 749-758, 2004.
21. Hosomi S., Yamashita T., Aoki M., Tohyama M. The p75 receptor is required for BDNF-induced differentiation of neural precursor cells. Biochem. Biophys. Res. Commun., 301: 1011-1015, 2003.
22. Lambiase A., Centofanti M., Micera A., Manni G.L., Mattei E., De Gregorio A., de Feo G., Bucci M.G., Aloe L. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch. Clin. Exp. Ophthalmol., 235: 780-785, 1997.
23. Lambiase A., Rama P., Bonini S., Caprioglio G., Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers [see comments]. N. Engl. J. Med., 338. 338: 1174-1180, 1998.
24. Lambiase A., Tirassa P., Micera A., Aloe L., Bonini S. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest. Ophthalmol. Vis. Sci., 46: 3800-3806, 2005.
25. Lambiase A., Pagani L., Di Fausto V., Sposato V., Coassin M., Bonini S., Aloe L. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res., 1127: 45-51, 2007.
26. Lambiase A., Coassin M., Tirassa P., Mantelli F., Aloe L. Nerve growth factor eye drops improve visual acuity and electrofunctional activity in agerelated macular degeneration: a case report. Ann. Ist. Super. Sanita, 45: 439-442, 2009a.
27. Lambiase A., Aloe L., Centofanti M., Parisi V., Mantelli F., Colafrancesco V., Manni G.L., Bucci M.G., Bonini S., Levi-Montalcini R. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc. Natl. Acad. Sci. U.S.A., 2009b.
28. Lenzi L., Coassin M., Lambiase A., Bonini S., Amendola T., Aloe L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res., 45: 1491-1500, 2005.
29. Lois C., Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science, 264: 1145-1148, 1994.
30. Pencea V., Bingaman K.D., Wiegand S.J., Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J. Neurosci., 21: 6706-6717, 2001.
31. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci., 24: 1217-1281, 2001.
32. Sposato V., Parisi V., Manni L., Antonucci M.T., Di Fausto V., Sornelli F., Aloe L. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vision Res., 49: 54-63, 2009.
33. Tirassa P., Triaca V., Amendola T., Fiore M., Aloe L. EGF and NGF injected into the brain of old mice enhance BDNF and ChAT in proliferating subventricular zone. J. Neurosci. Res., 72: 557-564, 2003.
34. Triaca V., Tirassa P. Circulating NGF antibody alters the distribution of NG2 and CD56 positive cells in the brain of an animal model of inflammatory disorder. Arch. Ital. Biol., 141: 127-139, 2003.
35. Tuszynski M.H., Thal L., Pay M., Salmon D.P., Bakay R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., Conner J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med., 11: 551-555, 2005.
36. Vaka S.R., Sammeta S.M., Day L.B., Murthy S.N. Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J. Pharm. Sci., 98: 3640-3646, 2009.
37. Vereczki V., Koves K., Csaki A., Grosz K., Hoffman G.E., Fiskum G. Distribution of hypothalamic, hippocampal and other limbic peptidergic neuronal cell bodies giving rise to retinopetal fibers: anterograde and retrograde tracing and neuropeptide immunohistochemical studies. Neuroscience, 140: 1089-1100, 2006.
38. Winner B., Cooper-Kuhn C.M., Aigner R., Winkler J., Kuhn H.G. Long-term survival and cell death of newly generated neurons in the adult rat olfactory bulb. Eur. J. Neurosci., 16: 1681-1689, 2002.
39. Young K.M., Merson T.D., Sotthibundhu A., Coulson E.J., Bartlett P.F. p75 neurotrophin receptor expression defines a population of BDNF-responsive neurogenic precursor cells. J. Neurosci., 27: 5146-5155, 2007.
40. Zhao H.M., Liu X.F., Mao X.W., Chen C.F. Intranasal delivery of nerve growth factor to protect the central nervous system against acute cerebral infarction. Chin. Med. Sci. J., 19: 257-261, 2004.
41. Zigova T., Pencea V., Wiegand S.J., Luskin M.B. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol. Cell. Neurosci., 11: 234-245, 1998.